29/11/2025
Orforglipron is a next-generation treatment under development for weight management and type 2 diabetes. Belonging to the GLP-1 receptor agonist family, it shares similarities with injectable treatments like Wegovy® and Mounjaro®, but with one key difference- it’s taken orally.
Explore Orforglipron research and UK clinical trials. Learn how this daily oral GLP-1 tablet supports weight loss, diabetes care, and when it may launch.